160 related articles for article (PubMed ID: 36069783)
1. Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas.
Araujo-Castro M; Mínguez Ojeda C; García Centeno R; López-García MC; Lamas C; Hanzu FA; Mora M; Del Castillo Tous M; Rodríguez de Vera Gómez P; Parra Ramírez P; Alvarez-Escola C; Blanco Carrera C; Barahona San Millán R; Recasens M; Valdés N; Gracia Gimeno P; de Miguel Novoa P; Vicente A; Manjón L; García Sanz I; Michalopoulou T; Calatayud M
Endocr Relat Cancer; 2022 Dec; 29(12):645-655. PubMed ID: 36069783
[TBL] [Abstract][Full Text] [Related]
2. Treatment and outcomes in pheochromocytomas and paragangliomas: a study of 110 cases from a single center.
Falhammar H; Kjellman M; Calissendorff J
Endocrine; 2018 Dec; 62(3):566-575. PubMed ID: 30220006
[TBL] [Abstract][Full Text] [Related]
3. Nonselective Compared With Selective α-Blockade Is Associated With Less Intraoperative Hypertension in Patients With Pheochromocytomas and Paragangliomas: A Retrospective Cohort Study With Propensity Score Matching.
Kong H; Li N; Yang XC; Nie XL; Tian J; Wang DX
Anesth Analg; 2021 Jan; 132(1):140-149. PubMed ID: 32675634
[TBL] [Abstract][Full Text] [Related]
4. Differences in intraoperative and surgical outcomes between normotensive pheochromocytomas and sympathetic paragangliomas (PPGLs) and hypertensive PPGLs: results from the PHEO-RISK STUDY.
Araujo-Castro M; García Sanz I; Mínguez Ojeda C; Calatayud M; Hanzu F; Mora M; Vicente A; Blanco Carrera C; De Miguel Novoa P; López García MDC; Manjón-Miguélez L; Rodríguez de Vera P; Del Castillo Tous M; Barahona San Millán R; Recasens M; Tomé Fernández-Ladreda M; Valdés N; Gracia Gimeno P; Robles Lazaro C; Michalopoulou T; Álvarez Escolá C; García Centeno R; Lamas C
J Endocrinol Invest; 2023 Apr; 46(4):805-814. PubMed ID: 36323983
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service.
Kim JH; Moon H; Noh J; Lee J; Kim SG
Endocrinol Metab (Seoul); 2020 Mar; 35(1):157-164. PubMed ID: 32207276
[TBL] [Abstract][Full Text] [Related]
6. Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas.
Zhao L; Zhang T; Meng X; Zhang Z; Zhou Y; Fan H; Liu Y; Zhou X; Zhu H
Ann Med; 2023 Dec; 55(1):2203945. PubMed ID: 37129505
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion.
Geroula A; Deutschbein T; Langton K; Masjkur J; Pamporaki C; Peitzsch M; Fliedner S; Timmers HJLM; Bornstein SR; Beuschlein F; Stell A; Januszewicz A; Prejbisz A; Fassnacht M; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2019 Oct; 181(4):409-420. PubMed ID: 31370000
[TBL] [Abstract][Full Text] [Related]
8. Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.
Kim KY; Kim JH; Hong AR; Seong MW; Lee KE; Kim SJ; Kim SW; Shin CS; Kim SY
PLoS One; 2016; 11(12):e0168413. PubMed ID: 27992508
[TBL] [Abstract][Full Text] [Related]
9. Clinical differences between small and large pheochromocytomas and paragangliomas.
Zhao L; Li Z; Meng X; Fan H; Zhang Z; Zhang Z; Liu Y; Zhou X; Zhu H
Front Endocrinol (Lausanne); 2023; 14():1087506. PubMed ID: 36967797
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas.
Ruff SM; Ayabe RI; Malekzadeh P; Good ML; Wach MM; Gonzales MK; Tirosh A; Nilubol N; Pacak K; Kebebew E; Patel D
J Surg Res; 2019 Nov; 243():1-7. PubMed ID: 31146085
[TBL] [Abstract][Full Text] [Related]
11. Pheochromocytoma and paraganglioma: An emerging cause of secondary osteoporosis.
Yokomoto-Umakoshi M; Umakoshi H; Fukumoto T; Matsuda Y; Nagata H; Ogata M; Kawate H; Miyazawa T; Sakamoto R; Ogawa Y;
Bone; 2020 Apr; 133():115221. PubMed ID: 31940499
[TBL] [Abstract][Full Text] [Related]
12. Pseudohypoxic pheochromocytomas and paragangliomas dominate in children.
Redlich A; Pamporaki C; Lessel L; Frühwald MC; Vorwerk P; Kuhlen M
Pediatr Blood Cancer; 2021 Jul; 68(7):e28981. PubMed ID: 33682326
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients.
Kim JH; Lee HC; Kim SJ; Lee KE; Jung KC
Front Endocrinol (Lausanne); 2022; 13():816833. PubMed ID: 35282440
[TBL] [Abstract][Full Text] [Related]
14. Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas.
Araujo-Castro M; García Sanz I; Mínguez Ojeda C; Hanzu F; Mora M; Vicente A; Blanco Carrera C; de Miguel Novoa P; López García MDC; Lamas C; Manjón-Miguélez L; Del Castillo Tous M; Rodríguez de Vera P; Barahona San Millán R; Recasens M; Tomé Fernández-Ladreda M; Valdés N; Gracia Gimeno P; Robles Lazaro C; Michalopoulou T; Álvarez Escolá C; García Centeno R; Barca-Tierno V; Herrera-Martínez AD; Calatayud M
Front Endocrinol (Lausanne); 2023; 14():1279828. PubMed ID: 38155946
[TBL] [Abstract][Full Text] [Related]
15. Acute cardiac complications and subclinical myocardial injuries associated with pheochromocytoma and paraganglioma.
Zhou J; Xuan H; Miao Y; Hu J; Dai Y
BMC Cardiovasc Disord; 2021 Apr; 21(1):203. PubMed ID: 33882857
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and progression of carbohydrate disorders in patients with pheochromocytoma/paraganglioma: retrospective single-center study.
Elenkova A; Matrozova J; Vasilev V; Robeva R; Zacharieva S
Ann Endocrinol (Paris); 2020 Feb; 81(1):3-10. PubMed ID: 32067697
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic instability during percutaneous ablation of extra-adrenal metastases of pheochromocytoma and paragangliomas: a case series.
Deljou A; Kohlenberg JD; Weingarten TN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
BMC Anesthesiol; 2018 Nov; 18(1):158. PubMed ID: 30400849
[TBL] [Abstract][Full Text] [Related]
18. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center.
Pham TH; Moir C; Thompson GB; Zarroug AE; Hamner CE; Farley D; van Heerden J; Lteif AN; Young WF
Pediatrics; 2006 Sep; 118(3):1109-17. PubMed ID: 16951005
[TBL] [Abstract][Full Text] [Related]
19. Surgical Resection of Pheochromocytomas and Paragangliomas is Associated with Lower Cholesterol Levels.
Good ML; Malekzadeh P; Ruff SM; Gupta S; Copeland A; Pacak K; Nilubol N; Kebebew E; Patel D
World J Surg; 2020 Feb; 44(2):552-560. PubMed ID: 31531722
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas.
Araujo-Castro M; García Sanz I; Mínguez Ojeda C; Hanzu F; Mora M; Vicente A; Blanco Carrera C; Miguel Novoa P; López García MDC; Lamas C; Manjón-Miguélez L; Del Castillo Tous M; Rodríguez de Vera P; Barahona San Millán R; Recasens M; Fernández-Ladreda MT; Valdés N; Gracia Gimeno P; Robles Lazaro C; Michalopoulou T; Álvarez Escolá C; García Centeno R; Calatayud M
J Hypertens; 2024 Feb; 42(2):252-259. PubMed ID: 37851004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
